C2-ceramide influences alveolar epithelial barrier function by downregulating Zo-1, occludin and claudin-4 expression
Authors:
- 24 January 2017
- journal article
- research article
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 27 (4) , 293-297
Abstract
Noncardiogenic lung edema is a key factor affecting the prognosis of acute lung injury (ALI). Previous studies have been focused on regulatory roles of ceramide on lung vascular endothelial barrier functions and had already identified ceramide as mediator involved in the formation of lung edema. However, the effects of ceramide on lung epithelial barrier were still unknown. This study aimed to investigate the effects of ceramide on the barrier function of alveolar epithelial cells. Primary mouse alveolar type II epithelial cells (AECII) were grown on Transwell polyester membranes to construct monolayer, and stimulated with different concentrations of ceramide. Transepithelial resistance (TER) was measured to assess the epithelial cell permeability. Western blotting and real-time quantitative polymerase chain reaction were used to detect the mRNA and protein levels of tight junction, respectively. After incubation with different concentrations of c2-ceramide, TER of AECII monolayer decreased significantly in a dose-dependent manner. Moreover, expressions of ZO-1, occludin and claudin-4 were significantly reduced by c2-ceramide in the study. This study demonstrated that ceramide could increase alveolar epithelial cell monolayer permeability by downregulation of tight junction proteins. Therefore, modulation of ceramide expression may serve as a new therapeutic approach to treat acute lung injury.Keywords
Funding Information
- Natural Science Foundation of China (81400058)
This publication has 27 references indexed in Scilit:
- Ceramides: a potential therapeutic target in pulmonary emphysemaRespiratory Research, 2013
- Claudins and alveolar epithelial barrier function in the lungAnnals of the New York Academy of Sciences, 2012
- Hyperoxia disrupts pulmonary epithelial barrier in newborn rats via the deterioration of occludin and ZO-1Respiratory Research, 2012
- Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramidesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- The role of sphingolipids in respiratory diseaseTherapeutic Advances in Respiratory Disease, 2011
- Identification of Novel Functional Inhibitors of Acid SphingomyelinasePLOS ONE, 2011
- Protective effects of imipramine in murine endotoxin-induced acute lung injuryEuropean Journal of Pharmacology, 2010
- Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinaseEuropean Respiratory Journal, 2009
- Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A″-DTPA) conjugates show increased kidney accumulationJournal of Controlled Release, 2008
- Ceramide lances the lungsNature Medicine, 2004